Vertex Pharma (VRTX) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $540.26 -2.14%
Financial Fact:
Total costs and expenses: 432.51M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Total costs and expenses: 432.51M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of ($0.39), $0.09 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $309.8 million versus the consensus estimate of $245.84 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
